Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, October 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 16 news outlets
policy: 1 policy source

twitter: 6 X users
patent: 8 patents

Readers on

mendeley: 263 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1 policy document that references this research output.

WHO preferred product characteristics for monoclonal antibodies for HIV prevention

Cited by World Health Organization (WHO) on 21 Jul 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.